A large MS brain study linked specific pathological features with genetic variants, disease severity, and myelin repair, ...

Millions of people survive heart attacks each year, yet many go on to experience memory lapses, difficulty concentrating, and ...

Why does multiple sclerosis progress quickly in some people, while others remain stable for years? Researchers from the ...

A study found multiple sclerosis affects social life, work, finances, and education, highlighting the need for more ...

There is currently no cure or treatment for the rare brain disease, but families and researchers hope that could soon change.

The FDA has given the green light for a first-in-human trial testing PTD802, an oral remyelination therapy for multiple sclerosis. The treatment candidate from Pheno Therapeutics is designed to boost ...

BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) gradually strips people of command over their own bodies, advancing steadily with no available cure. More than 2.9 million people across the ...

Rather than targeting the immune system, Quantum BioPharma’s Lucid-MS targets the myelin sheath. The case for Lucid-MS is grounded in more than a decade of rigorous science. Quantum BioPharma's path ...

Department of Anesthesiology and Perioperative Medicine, People’s Hospital of Zhengzhou University, Henan Provincial People’s Hospital, Zhengzhou, Henan 450003, P.R. China Academy of Medical Sciences ...

Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...